Electromagnetic Field Effects of Mobile Communication (LTE) on Sleep in the Context of Genetic Variation
1 other identifier
interventional
34
1 country
1
Brief Summary
The effect of electromagnetic fields of the latest standard in mobile communication (long term evolution, LTE) on sleep is studied in healthy, young individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 31, 2017
CompletedFirst Submitted
Initial submission to the registry
February 23, 2017
CompletedFirst Posted
Study publicly available on registry
March 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedJanuary 30, 2023
January 1, 2023
5.7 years
February 23, 2017
January 27, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
electroencephalographic power during sleep after LTE exposure
electroencephalogram (EEG)
up to 9 hours (approximately 11 p.m. to 8 a.m.)
Study Arms (2)
LTE field
EXPERIMENTALsham field
SHAM COMPARATORInterventions
electromagnetic field of the latest standard in mobile communication (long term evolution, LTE)
Eligibility Criteria
You may qualify if:
- Age 18-30 years
- German knowledge (reading and writing)
- Right-handedness
- Body mass index (BMI) 18.5-25.0 kg/m2
- Mobile communication (phone calls) less than 2 hours per week
- Moderate alcohol consumption (less than 5 alcoholic beverages per week)
- Moderate caffeine consumption (less than 5 caffeinated foods per day, e.g. coke, coffee, energy drinks, green or black tea, chocolate)
- Informed consent
You may not qualify if:
- Travels across more than 2 time zones in the last 30 days or during the study
- Nocturnal shift work
- Extreme chronotype or extreme sleep duration (less than 5 hours or more than 10 hours on average)
- Sleep disorders or problems
- Severe acute or chronic neurological, mental or general health disorders, which might impair the participant's safety or affect the study's outcome
- Use of medication (regular or during the study), which might affect the study's outcome
- Recreational drug use
- Smoking (or other tobacco products)
- Severe skin allergies
- Relevant findings in physical examination or during the screening night (e.g. sleep disorders)
- Participation in an other clinical trial in the last 30 days or during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Zurich, Institute of Pharmacology and Toxicology
Zurich, 8057, Switzerland
Related Publications (1)
Eicher C, Marty B, Achermann P, Huber R, Landolt HP. Reduced subjective sleep quality in people rating themselves as electro-hypersensitive: An observational study. Sleep Med. 2024 Jan;113:165-171. doi: 10.1016/j.sleep.2023.11.029. Epub 2023 Nov 21.
PMID: 38029625DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Hans-Peter Landolt
University of Zurich, Institute of Pharmacology and Toxicology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2017
First Posted
March 9, 2017
Study Start
January 31, 2017
Primary Completion
September 30, 2022
Study Completion
September 30, 2022
Last Updated
January 30, 2023
Record last verified: 2023-01